![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MAPKAP1 |
Gene summary for MAPKAP1 |
![]() |
Gene information | Species | Human | Gene symbol | MAPKAP1 | Gene ID | 79109 |
Gene name | MAPK associated protein 1 | |
Gene Alias | JC310 | |
Cytomap | 9q33.3 | |
Gene Type | protein-coding | GO ID | GO:0001932 | UniProtAcc | Q9BPZ7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79109 | MAPKAP1 | CCI_2 | Human | Cervix | CC | 2.19e-12 | 1.38e+00 | 0.5249 |
79109 | MAPKAP1 | CCI_3 | Human | Cervix | CC | 4.16e-13 | 1.09e+00 | 0.516 |
79109 | MAPKAP1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.39e-05 | -4.58e-01 | 0.0155 |
79109 | MAPKAP1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.25e-03 | -2.93e-01 | -0.1808 |
79109 | MAPKAP1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.65e-04 | -4.92e-01 | -0.1207 |
79109 | MAPKAP1 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.88e-02 | -2.07e-01 | -0.1464 |
79109 | MAPKAP1 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.05e-02 | -2.20e-01 | -0.1001 |
79109 | MAPKAP1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.16e-05 | -4.87e-01 | 0.096 |
79109 | MAPKAP1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.46e-02 | -4.62e-01 | 0.0338 |
79109 | MAPKAP1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.39e-04 | -2.70e-01 | 0.0674 |
79109 | MAPKAP1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 5.26e-11 | -3.95e-01 | 0.294 |
79109 | MAPKAP1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.35e-15 | -4.69e-01 | 0.3005 |
79109 | MAPKAP1 | A002-C-010 | Human | Colorectum | FAP | 2.07e-04 | -7.31e-02 | 0.242 |
79109 | MAPKAP1 | A001-C-207 | Human | Colorectum | FAP | 2.22e-05 | -4.08e-01 | 0.1278 |
79109 | MAPKAP1 | A015-C-203 | Human | Colorectum | FAP | 3.19e-33 | -5.10e-01 | -0.1294 |
79109 | MAPKAP1 | A015-C-204 | Human | Colorectum | FAP | 2.61e-05 | -3.93e-01 | -0.0228 |
79109 | MAPKAP1 | A014-C-040 | Human | Colorectum | FAP | 1.97e-05 | -6.02e-01 | -0.1184 |
79109 | MAPKAP1 | A002-C-201 | Human | Colorectum | FAP | 8.16e-11 | -3.73e-01 | 0.0324 |
79109 | MAPKAP1 | A002-C-203 | Human | Colorectum | FAP | 8.52e-05 | -1.83e-01 | 0.2786 |
79109 | MAPKAP1 | A001-C-119 | Human | Colorectum | FAP | 6.73e-15 | -7.08e-01 | -0.1557 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000697910 | Cervix | CC | response to oxidative stress | 102/2311 | 446/18723 | 2.99e-10 | 4.36e-08 | 102 |
GO:00510566 | Cervix | CC | regulation of small GTPase mediated signal transduction | 75/2311 | 302/18723 | 1.54e-09 | 1.74e-07 | 75 |
GO:00072656 | Cervix | CC | Ras protein signal transduction | 79/2311 | 337/18723 | 9.49e-09 | 7.77e-07 | 79 |
GO:006219710 | Cervix | CC | cellular response to chemical stress | 76/2311 | 337/18723 | 1.01e-07 | 5.25e-06 | 76 |
GO:003459910 | Cervix | CC | cellular response to oxidative stress | 63/2311 | 288/18723 | 3.58e-06 | 9.50e-05 | 63 |
GO:00465785 | Cervix | CC | regulation of Ras protein signal transduction | 44/2311 | 189/18723 | 2.05e-05 | 3.73e-04 | 44 |
GO:00309019 | Cervix | CC | midbrain development | 26/2311 | 90/18723 | 2.12e-05 | 3.82e-04 | 26 |
GO:002176210 | Cervix | CC | substantia nigra development | 16/2311 | 44/18723 | 3.81e-05 | 5.99e-04 | 16 |
GO:00181057 | Cervix | CC | peptidyl-serine phosphorylation | 63/2311 | 315/18723 | 6.65e-05 | 9.47e-04 | 63 |
GO:00182096 | Cervix | CC | peptidyl-serine modification | 66/2311 | 338/18723 | 9.58e-05 | 1.25e-03 | 66 |
GO:00488579 | Cervix | CC | neural nucleus development | 18/2311 | 64/18723 | 5.42e-04 | 5.23e-03 | 18 |
GO:00510585 | Cervix | CC | negative regulation of small GTPase mediated signal transduction | 15/2311 | 56/18723 | 2.60e-03 | 1.80e-02 | 15 |
GO:00331353 | Cervix | CC | regulation of peptidyl-serine phosphorylation | 29/2311 | 144/18723 | 5.10e-03 | 3.01e-02 | 29 |
GO:00465804 | Cervix | CC | negative regulation of Ras protein signal transduction | 13/2311 | 49/18723 | 5.34e-03 | 3.10e-02 | 13 |
GO:0006979 | Colorectum | AD | response to oxidative stress | 145/3918 | 446/18723 | 5.16e-09 | 3.23e-07 | 145 |
GO:0062197 | Colorectum | AD | cellular response to chemical stress | 109/3918 | 337/18723 | 5.33e-07 | 1.95e-05 | 109 |
GO:0034599 | Colorectum | AD | cellular response to oxidative stress | 94/3918 | 288/18723 | 2.03e-06 | 6.02e-05 | 94 |
GO:0007265 | Colorectum | AD | Ras protein signal transduction | 104/3918 | 337/18723 | 1.01e-05 | 2.35e-04 | 104 |
GO:0051056 | Colorectum | AD | regulation of small GTPase mediated signal transduction | 94/3918 | 302/18723 | 1.81e-05 | 3.76e-04 | 94 |
GO:0021762 | Colorectum | AD | substantia nigra development | 21/3918 | 44/18723 | 6.60e-05 | 1.07e-03 | 21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04150 | Colorectum | MSS | mTOR signaling pathway | 47/1875 | 156/8465 | 1.19e-02 | 3.99e-02 | 2.44e-02 | 47 |
hsa041501 | Colorectum | MSS | mTOR signaling pathway | 47/1875 | 156/8465 | 1.19e-02 | 3.99e-02 | 2.44e-02 | 47 |
hsa041505 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa0415013 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa041502 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa0415011 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa041504 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415012 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415021 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
hsa041503 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MAPKAP1 | SNV | Missense_Mutation | novel | c.1100N>T | p.Ser367Leu | p.S367L | Q9BPZ7 | protein_coding | tolerated(0.28) | benign(0.053) | TCGA-F7-A620-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
MAPKAP1 | SNV | Missense_Mutation | novel | c.796N>A | p.Glu266Lys | p.E266K | Q9BPZ7 | protein_coding | deleterious(0.01) | possibly_damaging(0.553) | TCGA-MT-A67F-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MAPKAP1 | SNV | Missense_Mutation | c.766A>C | p.Lys256Gln | p.K256Q | Q9BPZ7 | protein_coding | deleterious(0.01) | possibly_damaging(0.876) | TCGA-HC-7736-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | novel | c.1012G>T | p.Asp338Tyr | p.D338Y | Q9BPZ7 | protein_coding | deleterious(0) | possibly_damaging(0.671) | TCGA-BR-7704-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MAPKAP1 | SNV | Missense_Mutation | rs759492877 | c.1414N>A | p.Ala472Thr | p.A472T | Q9BPZ7 | protein_coding | tolerated(0.57) | benign(0.302) | TCGA-BR-A4QL-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | xeloda | CR |
MAPKAP1 | SNV | Missense_Mutation | rs779168610 | c.971N>A | p.Arg324His | p.R324H | Q9BPZ7 | protein_coding | tolerated(0.34) | benign(0.025) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
MAPKAP1 | SNV | Missense_Mutation | c.1205T>C | p.Leu402Pro | p.L402P | Q9BPZ7 | protein_coding | deleterious(0) | probably_damaging(0.951) | TCGA-D7-A4YT-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | rs377752331 | c.601N>A | p.Ala201Thr | p.A201T | Q9BPZ7 | protein_coding | deleterious(0) | probably_damaging(0.919) | TCGA-D7-A4YV-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MAPKAP1 | SNV | Missense_Mutation | c.433C>T | p.Arg145Cys | p.R145C | Q9BPZ7 | protein_coding | deleterious(0.01) | probably_damaging(0.98) | TCGA-F1-6177-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | novel | c.247N>T | p.Arg83Cys | p.R83C | Q9BPZ7 | protein_coding | deleterious(0) | possibly_damaging(0.593) | TCGA-VQ-A8DU-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
79109 | MAPKAP1 | KINASE | inhibitor | OSI-027 | OSI-027 | |
79109 | MAPKAP1 | KINASE | inhibitor | MLN0128 | SAPANISERTIB | |
79109 | MAPKAP1 | KINASE | inhibitor | AZD8055 | AZD-8055 |
Page: 1 |